Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-hydroxytryptamine receptor 3 (5-HT₃ receptor) is a member of the serotonin receptor family, unique in being a ligand-gated ion channel rather than a G protein-coupled receptor. It mediates fast excitatory neurotransmission in both the central and peripheral nervous systems by allowing cation influx upon activation by serotonin (5-hydroxytryptamine). It is therapeutically important as a target for antiemetic drugs used especially during chemotherapy/radiotherapy. There is ongoing research into their role in neurodevelopmental disorders and psychiatric conditions due to their regulatory effects on neural circuits.
Agonist or antagonist binding to the 5-HT₃ receptor, modulating cation influx and neuronal excitability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-Hydroxytryptamine Receptor 3.